Swiss drugmaker Novartis on Friday agreed to buy a breast cancer drug candidate for up to $3 billion from U.S ... achievements as part of the deal.</p>.Some immune systems defeat cancer.
The company further revealed that batch number B2346B16 has been linked to at least four confirmed counterfeit cases across multiple countries, including Nigeria, Turkey and the Philippines, with identical false information ....
that most cancer drugs fail not because of the drug, but because of where it has to work ... This has given rise to a loose category of companies whose thesis is not a better drug so much as a better theory of the tumor.
War in the Middle East is disrupting the flow of critical medicines to the Gulf, imperilling supply routes for cancer drugs and other treatments that require refrigeration and fo ....